FTC Expands the Scope of Pharmaceutical Licensing Transactions That Will Be Subject to Premerger Review
By EsqSocial Corporation 13/11/13
The Federal Trade Commission (FTC) recently announced that it has finalized amendments to the premerger notification rules (HSR Rules) that provide a framework for determining when a transaction involving the transfer of rights to a pharmaceutical...
By: Wilson Sonsini Goodrich & Rosati